Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-004171
Filing Date
2025-11-24
Accepted
2025-11-24 16:42:45
Documents
1
Period of Report
2025-11-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3393
  Complete submission text file 0000905148-25-004171.txt   4781
Mailing Address 7 RAPPS RUN DRIVE MALVERN PA 19355
Business Address
Sorensen Mel (Reporting) CIK: 0001444783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 251513720

Mailing Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)